180 related articles for article (PubMed ID: 18805784)
1. Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury.
Hishikari K; Suzuki J; Ogawa M; Isobe K; Takahashi T; Onishi M; Takayama K; Isobe M
Cardiovasc Res; 2009 Jan; 81(1):123-32. PubMed ID: 18805784
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4.
Xiao CY; Yuhki K; Hara A; Fujino T; Kuriyama S; Yamada T; Takayama K; Takahata O; Karibe H; Taniguchi T; Narumiya S; Ushikubi F
Circulation; 2004 May; 109(20):2462-8. PubMed ID: 15123528
[TBL] [Abstract][Full Text] [Related]
3. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
[TBL] [Abstract][Full Text] [Related]
4. 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Arcoraci V; Minutoli L; Serrano M; Saitta A; Caputi AP
Eur J Pharmacol; 1997 Sep; 335(2-3):185-92. PubMed ID: 9369372
[TBL] [Abstract][Full Text] [Related]
5. Treatment with cardiotonic pills(®) after ischemia-reperfusion ameliorates myocardial fibrosis in rats.
Wei XH; Liu YY; Li Q; Yan L; Hu BH; Pan CS; Li ZX; Chang X; Fan JY; Zhao N; Sun K; Huang P; Wang CS; Fan TP; Han JY
Microcirculation; 2013 Jan; 20(1):17-29. PubMed ID: 22913380
[TBL] [Abstract][Full Text] [Related]
6. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation.
Ogawa M; Suzuki J; Kosuge H; Takayama K; Nagai R; Isobe M
Transplantation; 2009 Jun; 87(11):1645-53. PubMed ID: 19502955
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.
Bryson TD; Gu X; Khalil RM; Khan S; Zhu L; Xu J; Peterson E; Yang XP; Harding P
J Mol Cell Cardiol; 2018 May; 118():1-12. PubMed ID: 29522761
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory mechanism of prostaglandin e2 receptor 4 activation in rat experimental autoimmune myocarditis.
Ngoc PB; Suzuki J; Ogawa M; Hishikari K; Takayama K; Hirata Y; Nagai R; Isobe M
J Cardiovasc Pharmacol; 2011 Mar; 57(3):365-72. PubMed ID: 21383594
[TBL] [Abstract][Full Text] [Related]
10. [Effects of xiongshao capsule combined with ischemic postconditioning on monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in rat myocardium with ischemic reperfusion injury].
Zhang DW; Zhang L; Liu JG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1279-83. PubMed ID: 21302491
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
12. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
Morimoto H; Hirose M; Takahashi M; Kawaguchi M; Ise H; Kolattukudy PE; Yamada M; Ikeda U
Cardiovasc Res; 2008 Jun; 78(3):554-62. PubMed ID: 18267955
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart.
Wang N; Minatoguchi S; Chen X; Uno Y; Arai M; Lu C; Takemura G; Fujiwara T; Fujiwara H
Br J Pharmacol; 2004 Jul; 142(6):983-90. PubMed ID: 15210576
[TBL] [Abstract][Full Text] [Related]
14. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the monocyte chemoattractant protein-1 receptor pathway ameliorates myocardial injury in animal models of ischemia and reperfusion.
Al-Amran FG; Manson MZ; Hanley TK; Hainz DL
Pharmacology; 2014; 93(5-6):296-302. PubMed ID: 25170996
[TBL] [Abstract][Full Text] [Related]
16. [Effects of glucose-insulin-potassium cocktail on cardiac myocyte death and post-ischemic recovery cardiac functional recovery: the critical role of insulin].
Gao F; Shi DW; Wang XM; Dong L; Wang YM; Ma XL
Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):148-52. PubMed ID: 12816693
[TBL] [Abstract][Full Text] [Related]
17. Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes.
Kim YS; Kwon JS; Cho YK; Jeong MH; Cho JG; Park JC; Kang JC; Ahn Y
J Nutr Biochem; 2012 Nov; 23(11):1514-23. PubMed ID: 22402367
[TBL] [Abstract][Full Text] [Related]
18. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic myocytes generate monocyte chemoattractant protein-1 and mediate macrophage recruitment.
Kobara M; Sunagawa N; Abe M; Tanaka N; Toba H; Hayashi H; Keira N; Tatsumi T; Matsubara H; Nakata T
J Appl Physiol (1985); 2008 Mar; 104(3):601-9. PubMed ID: 18048593
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
Singh AD; Amit S; Kumar OS; Rajan M; Mukesh N
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):604-10. PubMed ID: 16700825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
